相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor xenograft modeling identifies an association between TCF4 loss and breast cancer chemoresistance
Gorka Ruiz de Garibay et al.
DISEASE MODELS & MECHANISMS (2018)
DNA Methylation of miR-7 is a Mechanism Involved in Platinum Response through MAFG Overexpression in Cancer Cells
Olga Vera et al.
THERANOSTICS (2017)
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer
Juliet D. French et al.
ONCOTARGET (2016)
PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
Shin Yup Lee et al.
SCIENTIFIC REPORTS (2016)
HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma
Xiupeng Lv et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance
Anil Belur Nagaraj et al.
ONCOTARGET (2015)
Analysis of Chemotherapeutic Response in Ovarian Cancers Using Publicly Available High-Throughput Data
Jesus Gonzalez Bosquet et al.
CANCER RESEARCH (2014)
ITF2 Prevents Activation of the β-Catenin-TCF4 Complex in Colon Cancer Cells and Levels Decrease With Tumor Progression
Hyun-Woo Shin et al.
GASTROENTEROLOGY (2014)
TCF4 (e2-2; ITF2): A schizophrenia-associated gene with pleiotropic effects on human disease
Katherinne Navarrete et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2013)
Down expression of LRP1B promotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer
Shaobin Ni et al.
CANCER SCIENCE (2013)
Combination of AT-101/cisplatin overcomes chemoresistance by inducing apoptosis and modulating epigenetics in human ovarian cancer cells
Burcak Karaca et al.
MOLECULAR BIOLOGY REPORTS (2013)
Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
Balazs Gyorffy et al.
PLOS ONE (2013)
EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
Alexandria M. Haslehurst et al.
BMC CANCER (2012)
RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Bo Li et al.
BMC BIOINFORMATICS (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Functional analysis of HOXD9 in human gliomas and glioma cancer stem cells
Masanao Tabuse et al.
MOLECULAR CANCER (2011)
Functional Diversity of Human Basic Helix-Loop-Helix Transcription Factor TCF4 Isoforms Generated by Alternative 5′ Exon Usage and Splicing
Mari Sepp et al.
PLOS ONE (2011)
Genomic imbalances in esophageal carcinoma cell lines involve Wnt pathway genes
Jacqueline Brown et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
Analysis and design of RNA sequencing experiments for identifying isoform regulation
Yarden Katz et al.
NATURE METHODS (2010)
IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer
I. Ibanez de Caceres et al.
ONCOGENE (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer)
L. Plowright et al.
BRITISH JOURNAL OF CANCER (2009)
RNA-Seq: a revolutionary tool for transcriptomics
Zhong Wang et al.
NATURE REVIEWS GENETICS (2009)
Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma
G. Akiri et al.
ONCOGENE (2009)
Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs
John L. Rinn et al.
CELL (2007)
Identification of novel target genes by an epigenetic reactivation screen of renal cancer
Inmaculada Ibanez de Caceres et al.
CANCER RESEARCH (2006)
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
S. Chattopadhyay et al.
ONCOGENE (2006)
Helix-loop-helix proteins and lymphocyte development
C Murre
NATURE IMMUNOLOGY (2005)
Alteration in copy numbers of genes as a mechanism for acquired drug resistance
K Yasui et al.
CANCER RESEARCH (2004)
Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients
J Akervall et al.
CLINICAL CANCER RESEARCH (2004)
ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation
FT Kolligs et al.
CANCER CELL (2002)
分享论文
